Publication | Open Access
Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration
73
Citations
25
References
2015
Year
Ranibizumab therapy for nAMD is associated with significant caregiver burden. Both disease impact and treatment frequency contributed to the overall burden.
| Year | Citations | |
|---|---|---|
Page 1
Page 1